Pharma Stocks
-
Why The Story Around Avadel Pharmaceuticals Is Evolving After Recent Analyst and Market Updates
Avadel Pharmaceuticals recently saw its consensus analyst price target edge up slightly from $20.20 to $20.30, reflecting a largely steady…
Read More » -
The Smartest Dividend Stock to Buy With $1,000 Right Now
Key Points The drug industry is facing scrutiny from investors because of changes in Washington and among consumers. Drug companies…
Read More » -
BridgeBio Pharma’s Encaleret Shows Positive Phase 2 Results, Normalizes Calcium in Post-Surgical Hypoparathyroidism
BridgeBio Pharma Inc. (NASDAQ:BBIO) is one of the most promising long-term stocks to buy. On September 6, BridgeBio Pharma announced that…
Read More » -
Jazz Pharmaceuticals plc (JAZZ) Advances Rare Cancer Portfolio with First CNS Glioma Therapy Approval
In this article, we will be taking a look at the 10 Best Pharma Stocks to Buy According to Billionaires.…
Read More » -
Alnylam Pharmaceuticals (ALNY): Evaluating Valuation After FDA Tightens Drug Advertising Disclosure Rules
Regulatory shakeups rarely go unnoticed on Wall Street, and the FDA’s latest crackdown on direct-to-consumer drug ads has certainly put…
Read More » -
Threat of US tariffs hangs over Sun Pharma’s specialty business
Sun Pharmaceutical Industries Ltd expects a limited impact from the US government’s most favoured nation (MFN) drug pricing directive, management…
Read More » -
KOSPI Hits New High As Tech And Pharma Lead Gains
What’s going on here? South Korea’s KOSPI index notched a record close of 3,486.19 on Tuesday, powered by heavyweight tech…
Read More » -
South Korean shares hit fresh record as chip, pharma stocks rally
End-of-day quote Monde 02:50:00 2025-09-23 am EDT 5-day change 1st Jan Change 3,486.19 PTS +0.51% +1.06% +45.29% Published on 09/23/2025…
Read More » -
Natco Pharma Faces Bearish Technical Trends Amid Market Evaluation Revision
Natco Pharma, a small-cap pharmaceutical company, has recently revised its stock evaluation amid challenging market conditions. Currently priced at 864.55,…
Read More » -
DongKoo Bio & Pharma Co., Ltd.’s (KOSDAQ:006620) Price Is Out Of Tune With Earnings
DongKoo Bio & Pharma Co., Ltd.’s (KOSDAQ:006620) price-to-earnings (or “P/E”) ratio of 26.2x might make it look like a strong…
Read More »
